BiotechTube
Home/Pipeline/Novel Formulations & Delivery Systems

Novel Formulations & Delivery Systems

Not Specified

Research/DevelopmentActive

Key Facts

Indication
Not Specified
Phase
Research/Development
Status
Active
Company
JSC Pharmstandard

About JSC Pharmstandard

Founded in 2003, JSC Pharmstandard has solidified its position as Russia's leading pharmaceutical manufacturer, driven by a mission to ensure the availability of affordable, high-quality medicines. Its strategy is built on massive-scale generic drug production, a broad portfolio covering over 30 dosage forms, and active support of national healthcare priorities, including import substitution. Recent partnerships with academic institutions and innovation camps underscore its focus on technological modernization within the generics and biosimilars space to maintain market leadership.

View full company profile

Therapeutic Areas

Broad GenericsCardiovascularCNSAnti-infectivesConsumer Health

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved